DxCodebookFY2027 · Oct 1, 2026 – Sep 30, 2027

C61 diagnosis code · Billable category · FY2027

C61 Malignant neoplasm of prostate

  • Billable
  • Not CC/MCC
  • HCC 23
  • POA reported

C61 ICD-10 code: a billable diagnosis code in FY2027; the category has no subdivisions.

Where it sits

  1. Chapter 2 Neoplasms (C00-D49)
  2. C60-C63 Malignant neoplasms of male genital organs (C60-C63)
  3. C61 Malignant neoplasm of prostate
CC / MCC
Neither
MS-DRG
715-716, 722-724
HCC V28
23
POA
Reported
Code Editor
–
Index entries
3

Instructions

At C61

Excludes1

  • malignant neoplasm of seminal vesicle (C63.7) C63.7

Use additional code

  • code, if applicable, to identify:
  • hormone sensitivity status (Z19.1-Z19.2) Z19.1 Z19.2
  • rising PSA following treatment for malignant neoplasm of prostate (R97.21) R97.21

Notes that also apply

Block C60-C63 instructions (Includes 1): printed on the block page.

Chapter 2 instructions (Notes 8): printed on the chapter 2 page.

Index entries

  • Adenocarcinomaductunspecified sitemale → C61
  • Carcinoma (malignant)endometrioidunspecified sitemale → C61
  • Cystadenocarcinomaendometrioidunspecified sitemale → C61

NCHS Alphabetic Index. Index first, then the Tabular List.

Medicare grouping and edits

CMS files for C61
CC / MCCNeither
Appendix BMDC 12 Diseases and Disorders of the Male Reproductive System, MS-DRG 715-716 (Male Reproductive System and Other O.R. Procedures for Malignancy with CC/MCC…); MDC 12 Diseases and Disorders of the Male Reproductive System, MS-DRG 722-724 (Malignancy, Male Reproductive System with MCC…)
Code Editor–
POAReported
HCC V28HCC 23 Prostate, Breast, and Other Cancers and Tumors

CMS: MS-DRG v44 (Appendix B, C), MCE v44, POA list FY2027, 2027 Initial ICD-10-CM Mappings. What the rows mean.

Hierarchy